Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3519316rdf:typepubmed:Citationlld:pubmed
pubmed-article:3519316lifeskim:mentionsumls-concept:C1135183lld:lifeskim
pubmed-article:3519316lifeskim:mentionsumls-concept:C0030940lld:lifeskim
pubmed-article:3519316lifeskim:mentionsumls-concept:C0033628lld:lifeskim
pubmed-article:3519316lifeskim:mentionsumls-concept:C0035031lld:lifeskim
pubmed-article:3519316lifeskim:mentionsumls-concept:C0699900lld:lifeskim
pubmed-article:3519316lifeskim:mentionsumls-concept:C0243125lld:lifeskim
pubmed-article:3519316lifeskim:mentionsumls-concept:C2825492lld:lifeskim
pubmed-article:3519316lifeskim:mentionsumls-concept:C1882074lld:lifeskim
pubmed-article:3519316pubmed:issue1lld:pubmed
pubmed-article:3519316pubmed:dateCreated1986-7-7lld:pubmed
pubmed-article:3519316pubmed:abstractTextThe susceptibility of porcine relaxin and 125I-polytyrosyl-porcine relaxin to degradation by 3 purified enzymes involved in the degradation of insulin and proinsulin was examined. Rat liver glutathione-insulin transhydrogenase (GIT), which cleaves disulfide bonds in insulin, catalyzed a time- and concentration-dependent increase in trichloroacetic acid (TCA)-soluble radioactivity of relaxin. The Sephadex G-50 profile of the reaction products revealed conversion to the A- and B-chains. Relaxin competitively inhibited the degradation of insulin by GIT; however, kinetic analysis revealed insulin to be preferred over relaxin as a substrate. Rat liver cytosol neutral thiol peptidase (NTP) catalyzed a time- and concentration-dependent increase in the TCA solubility of relaxin and a shift in the Sephadex G-50 radioactivity profile to low molecular weight products. Kinetic analysis revealed that insulin and B-chain are preferred over relaxin as substrates for NTP. A third enzyme, rat kidney neutral metalloendopeptidase, which degrades proinsulin and insulin C-peptide but not insulin, also did not degrade porcine relaxin.lld:pubmed
pubmed-article:3519316pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3519316pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3519316pubmed:languageenglld:pubmed
pubmed-article:3519316pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3519316pubmed:citationSubsetIMlld:pubmed
pubmed-article:3519316pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3519316pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3519316pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3519316pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3519316pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3519316pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3519316pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3519316pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3519316pubmed:statusMEDLINElld:pubmed
pubmed-article:3519316pubmed:monthJunlld:pubmed
pubmed-article:3519316pubmed:issn0303-7207lld:pubmed
pubmed-article:3519316pubmed:authorpubmed-author:VarandaniP...lld:pubmed
pubmed-article:3519316pubmed:authorpubmed-author:PilistineS...lld:pubmed
pubmed-article:3519316pubmed:issnTypePrintlld:pubmed
pubmed-article:3519316pubmed:volume46lld:pubmed
pubmed-article:3519316pubmed:ownerNLMlld:pubmed
pubmed-article:3519316pubmed:authorsCompleteYlld:pubmed
pubmed-article:3519316pubmed:pagination43-52lld:pubmed
pubmed-article:3519316pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:3519316pubmed:meshHeadingpubmed-meshheading:3519316-...lld:pubmed
pubmed-article:3519316pubmed:meshHeadingpubmed-meshheading:3519316-...lld:pubmed
pubmed-article:3519316pubmed:meshHeadingpubmed-meshheading:3519316-...lld:pubmed
pubmed-article:3519316pubmed:meshHeadingpubmed-meshheading:3519316-...lld:pubmed
pubmed-article:3519316pubmed:meshHeadingpubmed-meshheading:3519316-...lld:pubmed
pubmed-article:3519316pubmed:meshHeadingpubmed-meshheading:3519316-...lld:pubmed
pubmed-article:3519316pubmed:meshHeadingpubmed-meshheading:3519316-...lld:pubmed
pubmed-article:3519316pubmed:meshHeadingpubmed-meshheading:3519316-...lld:pubmed
pubmed-article:3519316pubmed:meshHeadingpubmed-meshheading:3519316-...lld:pubmed
pubmed-article:3519316pubmed:meshHeadingpubmed-meshheading:3519316-...lld:pubmed
pubmed-article:3519316pubmed:meshHeadingpubmed-meshheading:3519316-...lld:pubmed
pubmed-article:3519316pubmed:meshHeadingpubmed-meshheading:3519316-...lld:pubmed
pubmed-article:3519316pubmed:meshHeadingpubmed-meshheading:3519316-...lld:pubmed
pubmed-article:3519316pubmed:meshHeadingpubmed-meshheading:3519316-...lld:pubmed
pubmed-article:3519316pubmed:meshHeadingpubmed-meshheading:3519316-...lld:pubmed
pubmed-article:3519316pubmed:meshHeadingpubmed-meshheading:3519316-...lld:pubmed
pubmed-article:3519316pubmed:meshHeadingpubmed-meshheading:3519316-...lld:pubmed
pubmed-article:3519316pubmed:year1986lld:pubmed
pubmed-article:3519316pubmed:articleTitleDegradation of porcine relaxin by glutathione-insulin transhydrogenase and a neutral peptidase.lld:pubmed
pubmed-article:3519316pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3519316pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:3519316pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3519316lld:pubmed